These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3157072

  • 1. Reduced alpha-2-antiplasmin levels in the nephrotic syndrome.
    Francis RB, Sandler RM, Levitan D, Feinstein EI, Massry SG, Feinstein DI.
    Nephron; 1985; 39(4):325-9. PubMed ID: 3157072
    [Abstract] [Full Text] [Related]

  • 2. Use of noninvasive laboratory testing in the prediction of thrombosis in the nephrotic syndrome.
    Francis RB, Sandler RM, Levitan D, Weiner J, Feinstein EI, Massry SG, Feinstein DI.
    Am J Nephrol; 1984; 4(1):43-7. PubMed ID: 6731499
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive study of haemostasis in nephrotic syndrome.
    Panicucci F, Sagripanti A, Vispi M, Pinori E, Lecchini L, Barsotti G, Giovannetti S.
    Nephron; 1983; 33(1):9-13. PubMed ID: 6403881
    [Abstract] [Full Text] [Related]

  • 4. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C, Pillion G, Schlegel N, Douenias R, Mathieu H.
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [Abstract] [Full Text] [Related]

  • 5. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
    Du XH, Glas-Greenwalt P, Kant KS, Allen CM, Hayes S, Pollak VE.
    Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
    [Abstract] [Full Text] [Related]

  • 6. [Risk factors, atherosclerosis and thromboembolism in the nephrotic syndrome].
    Previato G, Loschiavo C, Tessitore N, Chiaramonte S, Oldrizzi L, Lupo A, Valvo E, Maschio G, Saporiti E.
    Minerva Nefrol; 1981 Oct; 28(3):421-30. PubMed ID: 7036020
    [No Abstract] [Full Text] [Related]

  • 7. [Concentration of thrombin antithrombin III complex and plasmin alpha 2-plasmin inhibitor complex in nephrotic syndrome].
    Kobayashi M, Katayama T, Ochiai S, Yoshida M, Kaito K, Masuoka H, Shimada T, Nishiwaki K, Sakai O.
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):653-8. PubMed ID: 1836241
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M, Rydzewski A, Małyszko JS, Małyszko J, Myśliwiec M.
    Przegl Lek; 1994 Jul; 51(2):77-81. PubMed ID: 8058973
    [Abstract] [Full Text] [Related]

  • 9. Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis.
    Kuhlmann U, Steurer J, Rhyner K, von Felten A, Briner J, Siegenthaler W.
    Clin Nephrol; 1981 May; 15(5):229-35. PubMed ID: 6166421
    [Abstract] [Full Text] [Related]

  • 10. Absence of a prothrombotic state in restenotic patients?
    Brack MJ, More RS, Pringle S, Gershlick AH.
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [Abstract] [Full Text] [Related]

  • 11. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK, McRoyan CJ, Sauter KL, Liu PI, Daniel SJ.
    Ann Clin Lab Sci; 1985 Jun; 15(2):165-70. PubMed ID: 3158265
    [Abstract] [Full Text] [Related]

  • 12. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
    Rodzynek JJ, Urbain D, Leautaud P, Wettendorff P, Delcourt A.
    Gut; 1984 Oct; 25(10):1050-6. PubMed ID: 6479679
    [Abstract] [Full Text] [Related]

  • 13. Hemostatic problems and thromboembolic complications in nephrotic children.
    Citak A, Emre S, Sâirin A, Bilge I, Nayir A.
    Pediatr Nephrol; 2000 Feb; 14(2):138-42. PubMed ID: 10684364
    [Abstract] [Full Text] [Related]

  • 14. [Thrombosis in various diseases: kidney diseases and blood coagulation].
    Narita M.
    Nihon Rinsho; 1986 May; 44(5):1104-9. PubMed ID: 3528570
    [No Abstract] [Full Text] [Related]

  • 15. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH.
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [Abstract] [Full Text] [Related]

  • 16. Hemostatic variables in nephrotic patients.
    Cucuianu M, Manasia M, Spînu C, Trif I, Marcuşu C, Roman S, Rus HG.
    Rom J Intern Med; 1991 Jul; 29(1-2):55-64. PubMed ID: 1844391
    [Abstract] [Full Text] [Related]

  • 17. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
    Hainaut J, Dhennin C, Guilbaud J.
    Nouv Rev Fr Hematol (1978); 1982 Jul; 24(6):375-81. PubMed ID: 6188103
    [Abstract] [Full Text] [Related]

  • 18. Nephrotic syndrome: a platelet hyperaggregability state.
    Rasedee A, Feldman BF.
    Vet Res Commun; 1985 Jul; 9(3):199-211. PubMed ID: 2930939
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The incidence of thromboembolism and the hemocoagulative background in patients with rheumatic heart disease.
    Fukuda Y, Nakamura K.
    Jpn Circ J; 1984 Jan; 48(1):59-66. PubMed ID: 6198532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.